LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Chagas Disease Unfamiliar to Many U.S. Physicians

By LabMedica International staff writers
Posted on 26 Oct 2010
Print article
Image: Trypanosoma cruzi, the causative agent of Chagas disease, in a thin blood film (photo courtesy Centers for Disease Control and Prevention [CDC]).
Image: Trypanosoma cruzi, the causative agent of Chagas disease, in a thin blood film (photo courtesy Centers for Disease Control and Prevention [CDC]).
Chagas disease manifests both as an acute or chronic disease, caused by the parasitic protozoa Trypanosoma cruzi and should no longer be thought of as exotic.

The diagnosis of Chagas disease can be made by observation of the parasite in a blood smear by microscopic examination. A thick and thin blood smear are made and stained for visualization of parasites. However, a blood smear works well only in the acute phase of infection when parasites are seen circulating in blood. For screening blood donated for transfusion, antibody detection tests are available.

The disease is spread by infected insects called triatomine bugs and is only transmitted on the American continents. Infection can also occur through blood transfusions, ingestion of contaminated food or drink, organ transplants, and from an infected mother to her unborn child. For obstetricians and gynecologists in the U.S., increased awareness around Chagas disease is important because many newly diagnosed patients are identified among blood donors who are women of childbearing age and at risk of transmitting the infection to their newborns. Although congenital Chagas disease is relatively rare in the US, the estimated 300 annual cases are similar to other rare diseases for which all newborns in the U.S. are routinely screened at birth.

A survey published in the October 2010 issue of the American Journal of Tropical Medicine and Hygiene, revealed that knowledge and understanding of this condition is low among obstetrician-gynecologists. The survey results found that only 3% of the physicians surveyed considered their knowledge about Chagas disease excellent or good compared to a large majority (88%) who described their knowledge as limited or very limited; almost 10% of those surveyed reported never having heard of the disease at all. One-third of survey respondents did not know what causes the disease, and only 58% were able to identify it correctly as a parasitic infection.

Jennifer R. Verani, M.D., from the Center for Disease Control and Prevention (CDC; Atlanta, GA; USA), said, "The good news about the survey results is that the majority of physicians respondents were not misinformed, they just did not have information about Chagas disease.” Edward T. Ryan, M.D., President of American Society of Tropical Medicine and Hygiene, added, "There are potentially 100,000 women living in the U.S. who are at risk of infecting their unborn babies. We need to educate obstetricians, family practitioners, nurse midwives, and pediatricians about Chagas, especially those who care for families from Latin America."

If left untreated, Chagas disease can cause complications such as cardiomyopathy, heart disease, heart failure, enlargement of the colon, enlargement of the esophagus and malnutrition. An estimated 20% to 30% of patients will develop the cardiovascular/digestive complications, decades after the initial infection.

Related Links:

CDC

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more